Puma Biotechnology (PBYI) EBT Margin (2017 - 2026)
Puma Biotechnology (PBYI) reported EBT Margin of 7.65% for Q1 2026, down 1475.0% on a YoY basis from 0.56% in Q1 2025, and down 133.73% quarter-over-quarter from 22.67% in Q4 2025.
Puma Biotechnology (PBYI) EBT Margin (2017 - 2026) Analysis & Trends
Puma Biotechnology has reported EBT Margin for 10 years, with the latest figure at 7.65% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 1475.0% year-over-year to 7.65%; the trailing twelve-month figure through Mar 2026 stood at 12.8% (up 943.0% YoY), and the FY2025 full-year result was 15.67%, changed N/A from the prior year.
- EBT Margin for Q1 2026 stood at 7.65%, down from 22.67% in the prior quarter.
- The five-year high for EBT Margin was 25.59% in Q3 2024, with the low at 20.08% in Q4 2024.
- Historically, EBT Margin has averaged 2.54% across 5 years, with a median of 2.93% in 2023.
- The largest YoY upside for EBT Margin was 9601 bps in 2022 against a maximum downside of 2423 bps in 2022.
- Puma Biotechnology's EBT Margin stood at 6.06% in 2022, then sank by 126 bps to 13.67% in 2023, then tumbled by 47 bps to 20.08% in 2024, then soared by 213 bps to 22.67% in 2025, then plunged by 134 bps to 7.65% in 2026.
- The last three EBT Margin figures came in at 7.65% (Q1 2026), 22.67% (Q4 2025), and 16.97% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | -7.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.65% |
| Dec 31, 2025 | 22.67% |
| Sep 30, 2025 | 16.97% |
| Jun 30, 2025 | 11.76% |
| Mar 31, 2025 | 7.10% |
| Dec 31, 2024 | -20.08% |
| Sep 30, 2024 | 25.59% |
| Jun 30, 2024 | -8.82% |
| Mar 31, 2024 | -10.50% |
| Dec 31, 2023 | -13.67% |
| Sep 30, 2023 | 10.71% |
| Jun 30, 2023 | 4.24% |
| Mar 31, 2023 | 2.93% |
| Dec 31, 2022 | -6.06% |
| Sep 30, 2022 | -0.51% |
| Jun 30, 2022 | 15.84% |
| Mar 31, 2022 | -7.36% |
| Dec 31, 2021 | 8.01% |
| Sep 30, 2021 | -96.52% |
| Jun 30, 2021 | -9.49% |